13G Filing: Barrett Ehrlich and Oncbiomune Pharmaceuticals, Inc (OBMP)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
THE BARRETT EDGE INC. (46 5,097,843 0 5,097,843 0 5,097,843 9.9%
BARRETT EHRLICH 5,097,843 0 5,097,843 0 5,097,843 9.9%

Page 1 of 6 SEC Filing

UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION

Washington,
D.C. 20549

SCHEDULE
13G
/A

Under the Securities Exchange
Act of 1934
(Amendment No. 1)*

ONCBIOMUNE
PHARMACEUTICALS, INC.

(Name of Issuer)

COMMON

(Title of
Class of Securities)

68235A101

(CUSIP Number)

BARRETT
EHRLICH, 260 MADISON AVE. NEW YORK, NY 10016

(Name, Address
and Telephone Number of Person
Authorized to Receive Notices and Communications)

SEPTEMBER 2, 2015

(Date of Event
which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

  Rule
13d-1(b)

  Rule
13d-1(c)

  Rule
13d-1(d)

* The remainder of this cover
page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Follow Theralink Technologies Inc. (OTCMKTS:OBMP)